Jingjing Wang

6.3k citations
225 papers · 4.2k indexed · 2 hit papers · h-index 33
Topics
Head and Neck Cancer Studies (13 papers)Head and Neck Surgical Oncology (12 papers)MicroRNA in disease regulation (12 papers)

In The Last Decade

Jingjing Wang

202 papers receiving 4.1k citations

Hit Papers

DNA topoisomerase II is required at the time of mitosis i...198520261998201219852024200400600

Peers

Jingjing Wang
Comparison fields: 5 of 179
  • Molecular Biology 1.8k
  • Surgery 803
  • Oncology 709
  • Cancer Research 570
  • Pulmonary and Respiratory Medicine 311
Replace Jin Hwan Kim with:
Jin Hwan Kim South Korea
Fen Wang China
Ting Xu China
Yu‐Chih Chen Taiwan
Xuelei Ma China
Ke Wang China
Masahiro Endo Japan
Szu‐Yuan Wu Taiwan
Kyu Eun Lee South Korea
Alison L. Allan Canada
Jingjing Wang relative to Jin Hwan Kim South Korea Jin Hwan Kim's profile →
Citations per field
00.5×2.6×
Jin Hwan Kim · 1×
Citations per year

Countries citing papers authored by Jingjing Wang

Since Specialization
Citations

This map shows the geographic impact of Jingjing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wang more than expected).

Fields of papers citing papers by Jingjing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wang. The network helps show where Jingjing Wang may publish in the future.

Co-authorship network of co-authors of Jingjing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Wang. A scholar is included among the top collaborators of Jingjing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Wang. Jingjing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 5
4 0
5 1
6 12
7 5
8 1
9 2
10 2
11 10
12 9
13 3
14 6
15 25
16 7
17 13
18 4
19 13
20 46

About Jingjing Wang

Jingjing Wang is a scholar working on Otorhinolaryngology, Cancer Research and Surgery, having authored 225 papers that have together received 4.2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (13 papers), Head and Neck Surgical Oncology (12 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cancer Research (570 citations), Otorhinolaryngology (143 citations) and Toxicology (95 citations). Jingjing Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Christian Holm, David Botstein, Takashi Goto, Hongjun Wang, Eleanor Barnes, Hys Ngan, Thomas Leung, Yuxin Jiang, Xingchen Peng and Michelle K.Y. Siu. Their work appears in journals such as Cell, Nucleic Acids Research and Advanced Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026